THE ROLE OF BMP-7 IN THE PATHOGENESIS AND TREATMENT OF OBSTRUCTIVE UROPATHIES

BMP-7 在梗阻性尿路病发病机制和治疗中的作用

基本信息

  • 批准号:
    8728847
  • 负责人:
  • 金额:
    $ 33.06万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2012
  • 资助国家:
    美国
  • 起止时间:
    2012-09-28 至 2017-08-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): While a variety of congenital obstructive uropathies are encountered in patients, these conditions have a common pathological endpoint: renal injury and loss of kidney function. Obstructive uropathies remain the leading cause of pediatric renal insufficiency and renal failure, in part, because the potential fo permanent renal injury remains even following the surgical correction of pathologies of the urinary tract. Recently, both basic science and clinical studies have demonstrated that the kidney is capable of restoring renal structure and function following injury. However, little is known about the innate repair mechanisms of the kidney and how they become impaired following chronic obstruction. Importantly, the BMP-7 protein is required for several processes that contribute to the repair of obstruction-induced renal injuries, including the cessaion of the TGF-b/fibrotic response to injury and the restoration of renal architecture. Nonetheless, the potential for renal recovery following prolonged obstruction is diminished due to the HDAC-dependent suppression of BMP-7 expression and the subsequent dysregulation of kidney repair. Given that BMP-7 is also required for nephrogenesis, it is likely that the los of BMP-7 expression in the obstructed kidney during the prenatal period also has significant, adverse effects on renal maturation and the long-term functional capacity of the kidney that are not yet understood. Since the loss of BMP-7 expression has been observed in patients with obstructive uropathies and other conditions that lead to chronic renal injury, it is imperative to develop a better understanding of this pivotal molecular event. Thus, this projec addresses the following specific aims: (AIM 1) The molecular mechanisms that lead to the suppression of Bmp-7 transcription following chronic obstruction will be determined by using a combination of pharmacologic and siRNA-based approaches for isoform-specific HDAC inhibition to assess the role of individual HDAC proteins in the regulation of BMP-7 expression and its downstream functions that contribute to the repair of obstruction-induced renal injuries. (AIM 2) The long-term effects of the loss of BMP-7 expression following chronic obstruction will be examined in the maturing kidney. An inducible Bmp-7 knockout mouse model will be used to mimic the obstruction- induced loss of BMP-7 expression and to determine its effects on renal maturation and the long-term functional capacity of the kidney. (AIM 3) The therapeutic potential of approaches designed to restore BMP-7 function in the obstructed kidney will be evaluated by examining their ability to stimulate the innate repair mechanisms of the kidney, ensure proper renal development, and preserve kidney function in a mouse model of congenital obstructive uropathy. Together, these studies will lead to a better understanding of the innate repair mechanisms of the kidney along with novel, therapeutic approaches that may be used to optimize the regenerative potential of the developing kidney during the treatment of congenital obstructive uropathies.
描述(由申请人提供):虽然患者会遇到各种先天性梗阻性尿路病,但这些疾病具有共同的病理终点:肾损伤和肾功能丧失。 梗阻性尿路病仍然是小儿肾功能不全和肾衰竭的主要原因,部分原因是即使在手术纠正尿路病变后,仍存在永久性肾损伤的可能性。最近,基础科学和临床研究都表明,肾脏能够在损伤后恢复肾脏结构和功能。然而,对肾脏的先天修复机制以及它们在慢性阻塞后如何受损知之甚少。重要的是,BMP-7蛋白是几个过程所必需的,这些过程有助于修复梗阻引起的肾损伤,包括阻断肾细胞的增殖。 TGF-β/纤维化对损伤的反应和肾结构的恢复。尽管如此, 由于BMP-7表达的HDAC依赖性抑制和随后的肾修复失调,长期阻塞后肾恢复的可能性降低。 鉴于BMP-7也是肾发生所需的,因此产前期间阻塞肾脏中BMP-7表达的丧失也可能具有显着的, 对肾脏成熟和肾脏的长期功能能力的不利影响尚不清楚。由于在梗阻性尿路病和其他导致慢性肾损伤的疾病患者中观察到BMP-7表达的缺失,因此必须更好地了解这一关键分子事件。因此,该项目涉及以下具体目标:(目的1)将通过使用用于同种型特异性HDAC抑制的药理学和基于siRNA的方法的组合来确定导致慢性阻塞后BMP-7转录抑制的分子机制,以评估个体HDAC蛋白在BMP-7转录调节中的作用。7的表达及其下游功能,有助于阻塞诱导的肾损伤的修复。 (AIM 2)将在成熟的肾脏中检查慢性阻塞后BMP-7表达丧失的长期影响。诱导型BMP-7敲除小鼠模型将用于模拟梗阻诱导的BMP-7表达丧失,并确定其对肾成熟和肾的长期功能能力的影响。(AIM 3)旨在恢复阻塞肾脏中BMP-7功能的方法的治疗潜力将通过检查它们刺激肾脏先天修复机制、确保肾脏正常发育和保护先天性阻塞性尿路病小鼠模型中的肾脏功能的能力来评估。总之,这些研究将导致更好地了解先天性修复机制的肾脏沿着新的,治疗方法,可用于优化再生潜力的发展中的肾脏在治疗先天性梗阻性尿路病。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

PAUL F AUSTIN其他文献

PAUL F AUSTIN的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('PAUL F AUSTIN', 18)}}的其他基金

THE ROLE OF BMP-7 IN THE PATHOGENESIS AND TREATMENT OF OBSTRUCTIVE UROPATHIES
BMP-7 在梗阻性尿路病发病机制和治疗中的作用
  • 批准号:
    8458345
  • 财政年份:
    2012
  • 资助金额:
    $ 33.06万
  • 项目类别:
THE ROLE OF BMP-7 IN THE PATHOGENESIS AND TREATMENT OF OBSTRUCTIVE UROPATHIES
BMP-7 在梗阻性尿路病发病机制和治疗中的作用
  • 批准号:
    8549219
  • 财政年份:
    2012
  • 资助金额:
    $ 33.06万
  • 项目类别:
Regulation of Bladder Smooth Muscle Hyperplasia
膀胱平滑肌增生的调节
  • 批准号:
    6899313
  • 财政年份:
    2003
  • 资助金额:
    $ 33.06万
  • 项目类别:
Regulation of Bladder Smooth Muscle Hyperplasia
膀胱平滑肌增生的调节
  • 批准号:
    6674533
  • 财政年份:
    2003
  • 资助金额:
    $ 33.06万
  • 项目类别:
Regulation of Bladder Smooth Muscle Hyperplasia
膀胱平滑肌增生的调节
  • 批准号:
    6788059
  • 财政年份:
    2003
  • 资助金额:
    $ 33.06万
  • 项目类别:
Regulation of Bladder Smooth Muscle Hyperplasia
膀胱平滑肌增生的调节
  • 批准号:
    7248762
  • 财政年份:
    2003
  • 资助金额:
    $ 33.06万
  • 项目类别:
Regulation of Bladder Smooth Muscle Hyperplasia
膀胱平滑肌增生的调节
  • 批准号:
    7085525
  • 财政年份:
    2003
  • 资助金额:
    $ 33.06万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 33.06万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 33.06万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 33.06万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 33.06万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 33.06万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 33.06万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 33.06万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 33.06万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 33.06万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 33.06万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了